Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis.
about
CMV in Hematopoietic Stem Cell TransplantationHow I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipientsNational Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus.Viral surveillance using PCR during treatment of AML and ALL.Human cytomegalovirus reactivation from latency: validation of a "switch" model in vitro.Impact of cytomegalovirus DNAemia on overall and non-relapse mortality in allogeneic stem cell transplant recipients.Coinfection with Human Cytomegalovirus Genetic Variants in Transplant Recipients and Its Impact on Antiviral T Cell Immune Reconstitution.CMV-specific immune reconstitution following allogeneic stem cell transplantation.Sequence homology between HLA-bound cytomegalovirus and human peptides: A potential trigger for alloreactivity.MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults.Early CMV-replication after allogeneic stem cell transplantation is associated with a reduced relapse risk in lymphoma.Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide.GMP-production of purified human B lymphocytes for the adoptive transfer in patients after allogeneic hematopoietic stem cell transplantation.Economic burden of preemptive treatment of CMV infection after allogeneic stem cell transplantation: a retrospective study of 208 consecutive patients.Who Is the Patient at Risk of CMV Recurrence: A Review of the Current Scientific Evidence with a Focus on Hematopoietic Cell Transplantation.Tissue polymerase chain reaction for the diagnosis of cytomegalovirus disease after allogeneic hematopoietic cell transplantation.Turning the tables on cytomegalovirus: targeting viral Fc receptors by CARs containing mutated CH2-CH3 IgG spacer domains.Cytomegalovirus-Specific CD8+ T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell Transplantation.Potential Beneficial Effects of Cytomegalovirus Infection after Transplantation.Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea.Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantationHuman Cytomegalovirus UL135 Interacts with Host Adaptor Proteins To Regulate Epidermal Growth Factor Receptor and Reactivation from LatencyThe impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancerDonor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood Transplantation
P2860
Q26740385-21AFC99B-E31F-4A51-8463-75D26680AA78Q28069489-E88D4DE1-5227-456A-A44A-7802FF586E4DQ38405199-8B6BD703-E53B-4B84-AFC4-A3229423FE17Q38602178-58C7114E-FB68-46B6-B370-FF7CA0C6D4FEQ38632347-2F354E3C-F426-4D80-B46A-5777D2668CBCQ38738282-B09924B2-C9BD-436B-AA4A-9E6B7D3EF93AQ38805253-E199E1A2-3F04-41B2-BAB5-FA5074B45CF0Q38856032-06E05CBB-E24F-4D86-8FB1-5FBFEAFA6775Q38942459-EEAD90D9-821C-4419-9590-A563B27BB89BQ40096975-1597435A-667C-4DBF-9AD6-A0D01DD1BE61Q40497816-C08BAEB1-7E30-4CED-87C3-A29E5F6D1A06Q40522033-4C6CEFA8-F93F-42F0-B7C7-126312CFB1BDQ42362027-05FF31B5-20D3-4860-A03D-C139BF4B8D53Q44456961-16924526-8112-4C4E-B5C4-65309F533055Q47152509-395ED422-945B-41D0-9708-E629D55A29C7Q47369032-6B39C7CF-2D3B-4B0A-9450-75A88ED9E28BQ47988142-A0880195-E534-4B2C-973F-C006B9F459FBQ50025140-D47293AC-6EE9-47D3-B9AD-9251B7F05E95Q52564628-92ACBD9C-FA3E-4376-848B-B24B81A82EF2Q52653110-71DBE24B-6D2A-4CBC-8CBB-18117B4CB0C0Q52728829-89B93E2C-15B8-4BB1-8832-B1604770691EQ57053200-A2EE8412-F21D-4DD8-AA8A-CDCE4E8A71A4Q57469888-A2E3D6E3-434F-4FBB-9649-AE2411685945Q58484770-A8BBD4CA-78A5-48BE-8345-95254508D058Q58572537-0AEC5EE7-53CA-4852-987A-E2CFF28E09A3
P2860
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Early cytomegalovirus reactiva ...... urrent era: a CIBMTR analysis.
@en
type
label
Early cytomegalovirus reactiva ...... urrent era: a CIBMTR analysis.
@en
prefLabel
Early cytomegalovirus reactiva ...... urrent era: a CIBMTR analysis.
@en
P2093
P2860
P1433
P1476
Early cytomegalovirus reactiva ...... urrent era: a CIBMTR analysis.
@en
P2093
A John Barrett
Ayman Saad
Bipin N Savani
Caroline A Lindemans
David Marks
Jaime S Green
Jeffery J Auletta
John R Wingard
Joseph H Antin
Kwang Woo Ahn
P2860
P304
P356
10.1182/BLOOD-2015-11-679639
P407
P577
2016-02-16T00:00:00Z